Articles tagged with Skin Disorders
People with eczema face a higher risk of developing shingles due to an altered skin immune response. Researchers analyzed UK database data and found that eczema severity was directly linked to increased shingles risk.
A systematic review of 47 randomized trials found that oral antihistamines do not improve eczema symptoms and may cause harm. Alternative treatments like moisturizers, topical anti-inflammatory treatments, and whole-body treatments like phototherapy and biologics are recommended.
A new study found a national mass drug administration (MDA) program drastically reduced scabies cases in Solomon Islands and Fiji by over 80%. The MDA, which involved ivermectin treatment, also decreased rates of skin infections and moderate-to-severe scabies.
A study by Kumamoto University researchers reveals a hidden communication network between the skin and bone marrow that drives psoriatic inflammation. This pathway highlights a crucial role for neutrophils in fueling psoriatic flare-ups, suggesting a promising new target for future therapies.
A new compound called ampyrone safely increases melanin production in human skin, offering a potential treatment for hypopigmentation disorders. The discovery could improve visual function and enhance patient quality of life for those with severe genetic forms of albinism.
A new research project using targeted gene technology aims to interrupt disease-causing signals at the genetic messaging stage. The therapy has shown promising results in early laboratory studies and is being tested in advanced human skin models to improve treatment precision and reduce side effects.
Researchers created an optical hydration index that combines multiple inputs and measurements to track skin hydration state. The system uses near-infrared optical imaging and temperature-aware algorithm for robust at-home monitoring.
A study has identified a genetic cause for pediatric-onset pyoderma gangrenosum, a rare inflammatory skin condition. The researchers discovered that a mutation in the OTULIN gene leads to the condition, which is characterized by recurrent ulcerating skin sores.
A new leishmaniasis vaccine, developed using CRISPR gene-editing technology, is set to begin testing in healthy people for its safety and immune response. The vaccine has shown strong results in mice and has cleared a key FDA hurdle, paving the way for Phase 2 trials aiming to understand its effectiveness.
A study by Radboud University Medical Center found that 75% of patients with stable psoriasis can safely reduce their biologic medication dosage by half, achieving similar symptom control. This reduction in dosage leads to fewer injections and saves up to €8,500 per patient per year.
A major new study has found that severe asthma patients are often battling other health conditions, with nearly all suffering from at least one major issue. The study identified three distinct profiles linked to how well asthma is controlled and the treatments needed, offering potential breakthroughs for improving care.
Researchers developed RegVelo, an AI framework that models cellular dynamics and gene regulation to predict cellular fate decisions. The model traces developmental trajectories and simulates regulatory interactions, providing insights into hidden drivers of development and potential therapeutic targets.
A new study reveals that facial itch sensations differ from those on the body due to distinct trigeminal and spinal pain pathways. The researchers found a functional divergence in neuropeptide signaling and central circuit engagement between the two systems, which was independent of peripheral innervation density.
Researchers have created lab-grown human skin organoids that can form complex microvascular networks similar to those in native human skin. These self-organizing structures function similarly to native skin, responding to inflammatory stimuli and re-growing after injury.
Scientists have discovered a natural extract that enhances the effectiveness of traditional sunscreens, providing longer-lasting protection against UV radiation. The new generation of sunscreens also offers antioxidant benefits, reducing the risk of skin cancer and premature aging.
A new study found that AI applications enhance consumer understanding of skin conditions by increasing accuracy and confidence. However, imperfect guessing accuracy remains, highlighting the need for further design improvements to facilitate better comprehension.
Researchers created a comprehensive mapping of over 1 million cells in normal adult human skin, identifying 45 unique cell types that vary across composition and arrangement. This study brings scientists closer to developing more targeted treatments for skin diseases like eczema and psoriasis.
Researchers used nonlinear dynamics to explore why eczema flare-ups happen and how to improve treatment outcomes. They found that small physiological changes can significantly increase the maintenance burden in long-term efforts to keep eczema in remission.
A new study published in Annals of Allergy, Asthma & Immunology shows that dupilumab treatment significantly restores skin barrier function and reduces inflammation in children with moderate-to-severe atopic dermatitis. The treatment also improves skin health in clinically unaffected areas, highlighting the systemic nature of the disease.
Researchers found that young mice developed strong skin inflammation in response to everyday allergens, revealing a brief window of vulnerability. The study suggests that early childhood represents a critical period for immune-driven skin disease, and that targeting this period may prevent allergic diseases from spreading.
A new review introduces a chronological and probabilistic model to explain the recurrence of autoimmune skin diseases like vitiligo. The model proposes that full disease manifestation is the outcome of genetic susceptibility and a series of environmental or internal biological hits.
Researchers discovered that a gene called ZNF750, active in skin cells, is essential for supporting Langerhans cells and building the body's first line of immune defense. The study found that ZNF750 controls the production of IL-34, a molecule released by skin cells that acts as a survival signal for Langerhans cells.
A revised approach to measuring treatment success for patients with chronic graft-versus-host disease has been proposed by the National Institutes of Health Consensus Project Task Force. The new criteria aim to capture clinically meaningful improvements in skin involvement, leading to better patient outcomes and more effective treatments.
Researchers at Kobe University have identified a specific bacterial strain, Staphylococcus epidermidis and Corynebacterium tuberculostearicum, as the primary causes of foot odor in Nagashima-type palmoplantar keratosis. Topical application of benzoyl peroxide reduces odor by decreasing C. tuberculostearicum levels.
Researchers have developed a new class of light-activatable drug candidates that could serve as a potential treatment for psoriasis. The approach targets the vitamin D receptor, which has been shown to have beneficial effects in psoriasis, but also poses risks due to its role in calcium metabolism.
A new study from North Carolina State University found that neutrophils play a role in the early stages of atopic dermatitis flares in dogs. The researchers compared skin samples from four dogs with house dust mite-induced AD with samples from five healthy, or control, dogs.
A study reports on the underdiagnosis of 'topical steroid withdrawal syndrome' (TSW), a condition triggered by sudden or tapered use of steroid creams for inflammatory skin conditions. TSW can lead to severe symptoms, including skin reddening, burning, itching, and systemic problems like insomnia and depression.
Researchers found that indoor tanning users in their 30s and 40s have more skin mutations than people twice their age, particularly in areas exposed to tanning beds. This can lead to an increased risk of skin cancer, including melanoma.
A 47-year-old man from New Jersey died after consuming beef due to a tick-borne meat allergy caused by the Lone Star tick's alpha-gal sugar. Researchers identified the allergy and its link to fatal anaphylaxis, urging physicians to investigate severe abdominal pain after eating red meat in areas with high Lone Star tick populations.
A new study found that COVID-19 vaccination is associated with a significant reduction in infections and allergic complications among children with atopic dermatitis. The researchers analyzed data from over 5,700 vaccinated and unvaccinated pediatric patients and found lower rates of multiple infections and allergic conditions.
Research suggests that people with allergic conditions like eczema, asthma, and hay fever are more likely to experience complications after surgery, including infections, scar tissue buildup, and implant rupture. These conditions can lead to increased inflammation and immune system changes, making it harder for the body to heal.
Scientists have discovered that immune cells shed their glycocalyx layer to move into tissues, changing the understanding of inflammatory skin diseases like psoriasis. This finding may lead to new approaches in developing drugs targeting immune cell movement and treating infections and inflammatory diseases.
A novel therapeutic candidate has been developed to treat severe cutaneous adverse reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The compound suppresses disease-specific keratinocyte death, demonstrating its efficacy in preclinical studies.
Researchers found that 14.5% of patients with a first episode of psychosis had dermatological symptoms, which were linked to higher levels of depression and risk of suicide. The study suggests that skin conditions may serve as an advance marker for mental health risk, similar to blood tests for cancer or heart disease.
A topical formulation has been shown to reduce the incidence of hand-foot neuropathy in cancer patients undergoing chemotherapy, improving quality of life. The cream, developed at UMH, acts directly on neurosensory pain receptors, reducing hypersensitivity and tolerance to chemotherapy.
A groundbreaking vibroacoustic sensor could provide objective measurements of skin changes, enabling data-driven decisions on treatment effectiveness. The technology aims to reduce years of suffering for patients with eczema and psoriasis, improving health outcomes and reducing healthcare disparities.
A new study reveals that adults with atopic eczema are more likely to experience suicidal thoughts, with factors such as age of onset, obesity, and clinical features strongly associated with increased risk. The study highlights the need for healthcare professionals to better recognize and address these challenges.
A phase 3 clinical trial shows that genetically engineered skin grafts treat severe dystrophic epidermolysis bullosa, reducing pain and healing time. The treatment is part of a larger effort to improve EB patients' treatment options.
A research team at Nanjing University of Chinese Medicine discovered that plant-derived extracellular vesicles can deliver miRNAs across kingdoms to treat psoriasis. The researchers isolated perilla leaf-derived extracellular vesicle-like particles, which demonstrated potent antioxidant and anti-inflammatory activity.
A study found that teenage girls using multiple products on their faces increase the risk of skin irritation and allergy. The average cost of a daily skin care regimen is $168, with some costing over $500.
Researchers explore the psychological impact of chronic illnesses on patients with asthma and allergies, finding that fear, anxiety, and social stigma can greatly interfere with treatment. The American College of Allergy, Asthma, and Immunology discusses ways clinicians can mitigate these effects and provide better care for patients.
A clinical trial found that LUT014, a topical BRAF inhibitor, significantly reduced the severity of acne-like skin rashes caused by targeted therapy for colorectal cancer. Patients who received LUT014 had improved quality of life and were able to continue receiving their cancer treatment with reduced side effects.
A novel topical BRAF inhibitor gel called LUT014 has been shown to significantly reduce the severity of an acne-like rash in patients undergoing anti-EGFR therapies for colorectal cancer. The treatment's safety and effectiveness have been confirmed, offering a potential solution to managing this common side effect.
A study found that a topical formulation combining Kalonji (Nigella sativa) and Sirka (vinegar) showed therapeutic potential in treating mild to moderate acne vulgaris. The formulation was compared with a 5% benzoyl peroxide gel, with promising results but limitations such as a small sample size and short duration.
Researchers have identified a type of immune cell that produces extracellular matrix, strengthening the skin's defensive function and maintaining its integrity. This discovery may lead to new strategies for treating skin diseases, inflammation, diabetes, and age-related conditions.
Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa, a group of rare and severe skin disorders. The licensing agreement includes collaboration with Theravia to develop, register and commercialise the drug.
A new study published in Aging found that pioglitazone reduced the frequency of skin ulcers in Werner syndrome patients. The research suggests that pioglitazone's anti-inflammatory properties may help wounds heal faster and prevent ulcers from forming.
Women with infertility are at higher risk of developing SARD, including lupus and Sjögren's syndrome, even after accounting for pre-eclampsia and other pregnancy complications. Infertility treatments do not appear to increase this risk, suggesting that women may be undiagnosed or untreated.
A scoping review found associations between myositis disease activity and gluten exposure in patients with inflammatory myopathies and celiac disease. The study suggests that gluten may act as an exogenous antigen driving myositis in genetically predisposed patients.
The study combines AI with fluorescence photography to enhance skin diagnostics, allowing for earlier detection of skin conditions such as acne, photoaging, and hyperpigmentation. AI can pinpoint early indicators of skin conditions with greater accuracy and monitor changes over time for data-driven decisions.
This study found modestly increased risks of inflammatory bowel disease and bullous skin disorders in hospitalized patients infected with the Omicron variant. Booster vaccination mitigated long-term autoimmune sequelae risk.
Researchers have developed a slow-release system using bamboo vinegar and activated bamboo charcoal to combat acne. The study shows that the refined bamboo vinegar, adsorbed by the bamboo charcoal, exhibits a gradual release rate over two hours, effectively demonstrating its potential as an anti-acne cosmetic raw material.
A large-scale study investigated the relationship between childhood obesity and immune-mediated skin diseases (IMSDs), such as atopic dermatitis and psoriasis. The study found that obese children were more likely to develop these conditions, with changes in body weight affecting their risk of developing these diseases.
A clinical trial shows that JAK inhibitors improve autoimmune conditions such as alopecia areata, atopic dermatitis, and psoriasis in people with Down syndrome. The study also observed improvements in arthritis and decreased biomarkers of autoimmune thyroid disease.
Rashes are a common side effect of antiseizure medications, occurring in 2-16% of patients, with 5% indicating life-threatening reactions. Patients should seek medical treatment immediately if rashes develop, regardless of severity.
Researchers at Rutgers University have developed a unique prototype of a 'living bioelectronic' device that combines advanced electronics, living cells, and hydrogel to treat psoriasis. The patch continuously monitors skin conditions and provides real-time feedback, offering a potential treatment for psoriasis and other skin ailments.
Researchers from Nagoya University have successfully treated rare genetic skin disorders epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC) by transplanting genetically healthy skin to inflamed areas. Transplantation of healthy skin has been used as a treatment option for severe burn injuries.
A study by Chiba University researchers reveals that a specific variant of the HLA gene can trigger an endoplasmic reticulum stress response in skin cells when exposed to certain drugs, leading to drug eruptions. This newfound knowledge may form the basis for innovative treatment options.
Researchers at Kobe University discovered a new gene, FDFT1, responsible for porokeratosis by identifying epigenetic silencing. Patients with localized lesions didn't have inherited damaged copies, leading to a hypothesis that epigenetic changes are the first hit. The findings have implications for treatment and counseling.
A new study from Aarhus University reveals that only 67% of Danes registered with an ectodermal dysplasia diagnosis actually have congenital ectodermal dysplasia. The study identifies key characteristics, including abnormal teeth, skin issues, and nail problems, highlighting the need for collaboration across healthcare disciplines.